Celebrities and stars may be raving about the benefits of colon cleansing but a gastroenterologist from Charlottesville, Virginia urges consumers not to buy into the hype.

A batch of insulin stolen from North Carolina has turned up at a medical center in Houston and the Food and Drug Administration (FDA) is warning that patients and health care providers not use the product for fear it may be contaminated. In a Health Advisory issued this weekend, the FDA says that some vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have resurfaced from three lots, or a total of 129,000 vials, that had been stolen.

The U.S. Food & Drug Administration (FDA) issued a Public Health Advisory today to alert consumers to a possible link between Zicam nasally administered cold remedies and permanent loss of the sense of smell. According to the release, the affected products contain Zinc.

Beasley Allen firm, attorneys top Chambers USA list of best lawyers in America

A new medical procedure to find polyps in the colon may hold promise, but kinks still need to be worked out, according to a report in MedPage Today. The new procedure, called a capsule colonoscopy, offers an alternative to the traditional colonoscopy in which a patient undergoes a bowel cleansing process before going under local anesthesia and having a flexible telescopic camera passed through the rectum and bowel.

The makers of Remicade, a biologic treatment for various inflammatory disorders involving the immune system, have updated information on the medication to include a Boxed Warning of an invasive fungal infection and a rare type of T-cell Lymphoma. Some of the infections and diseases that resulted from use of Remicade have been fatal.

The Food and Drug Administration (FDA) and AS Medications Solutions LLC announced a nationwide recall of all lots of the 0.25 mg. heart medication digoxin manufactured by Caraco Pharmaceuticals Laboratories distributed prior to March 31, 2009 because they may differ in size and therefore may contain more or less of the active ingredient.

Salix Pharmaceuticals, makers of gastrointestinal drugs, is reporting a first-quarter loss, however sales of the company's products used to clean the bowel prior to colonoscopies enjoyed a 23 percent increase compared to first quarter 2008, according to The News & Observer.

The FDA has recently required the manufacturers of the drug metoclopramide, more commonly know as Reglan, to place a black box warning on its label alerting consumers of the link between the drug and a condition called tardive dyskinesia. Tardive dyskinesia is characterized by involuntary and repetitive movements of the body. A black box warning is the strongest warning that the FDA can require.

On December 11, 2008, the Food and Drug Administration (FDA) issued a "black box warning" to consumers and health care professionals that a rare but serious form of kidney failure, acute phosphate nephropathy, had been associated with the use of prescription oral sodium phosphate (OSP) products Visicol and Osmo Prep, both made by Salix Pharmaceuticals. The products are routinely prescribed for bowel cleansing prior to colonoscopy, radiographic procedures and surgery. Acute phosphate nephropathy is a rare but serious adverse event that is often permanent and may require chronic dialysis. The FDA expressed equal concern about the risks associated with over-the-counter (OTC) bowel clearing products such as Fleet Phospho-soda and Fleet Accu-Prep solutions.